Drug intelligence / Profile preview

estradiol + sertraline

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Transdermal, Topical, Vaginal, Intramuscular, Subcutaneous
01

Overview

Estradiol + sertraline is a combination of two active pharmaceutical ingredients: estradiol, a synthetic form of the endogenous estrogen hormone, and sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant. Estradiol acts primarily as an agonist at estrogen receptors to regulate gene expression and modulate reproductive and other physiological functions. Sertraline inhibits the sodium-dependent serotonin transporter, increasing synaptic serotonin levels in the central nervous system to exert antidepressant effects. This combination does not have an established fixed-dose product or unique brand name; it refers to concurrent use of both drugs for their respective indications—typically menopausal symptoms (estradiol) and mood disorders such as depression or anxiety (sertraline). There is some evidence that SSRIs like sertraline may interact with estrogenic pathways at the cellular level, potentially resulting in weak estrogenic or antiestrogenic effects when combined with estradiol[5]. However, no clinically significant pharmacokinetic drug-drug interactions are reported between these agents[1][2].

02

Targets

DAT (Dopamine plasma membrane transport protein)ESR1 (ERα)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)ESR2 (ERβ)

Beyond the preview

Go deeper on estradiol + sertraline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estradiol + sertraline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call